Creates provisions relating to reporting requirements for entities that participate in the 340B drug pricing program

HB 2081 requires Missouri-based entities participating in the federal 340B drug pricing program (which provides discounted medications to safety-net hospitals and clinics) to submit detailed annual reports to the state Department of Health and Senior Services by April 1st. The reports must include specific financial data on drug acquisition costs, payments received, charity care expenses, and how savings from the program are used. Entities failing to submit on time face daily fines of $1,000. The department will then compile and publicly share aggregated data annually, while keeping individual entity reports confidential. This bill directly affects Missouri hospitals, clinics, and outpatient facilities that operate under the federal 340B program.